Skip to content

The intervention of traditional Chinese medicine for hot flashes related to endocrine therapy of breast cancer:a double blind randomized clinical trial

The intervention of traditional Chinese medicine for hot flashes related to endocrine therapy of breast cancer:a double blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003683
Enrollment
Unknown
Registered
2013-08-29
Start date
2013-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

treatment group:Shugan Liangxue Decoction
control:Placebo

Sponsors

Beijing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. estrogen, progesterone receptor positive, need to endocrine therapy in breast cancer patients (confirmed by pathology), menopause or not postmenopausal patients; 2. with all of the following conditions: oral tamoxifen or aromatase inhibitors TAM for more than 1 month; hot flashes symptoms for more than a week; the classification method of women menopausal hot flushes Kupperman internationally recognized hot flashes per day more than 4 times; 3. the current without chemotherapy, corticosteroids or hormonal therapy; 4. in the group without while taking the medicine, such as traditional Chinese medicine, stop drug 2 weeks or more; 5. volunteered to participate in this test and can understand and answer the questions.

Exclusion criteria

Exclusion criteria: 1. patients with hypertension, diabetes, hyperthyroidism, not control; 2. in patients with pheochromocytoma; 3. at the same time, the use of other traditional Chinese medicine; 4. pregnant and lactating patients.

Design outcomes

Primary

MeasureTime frame
kupperman;

Countries

China

Contacts

Public ContactPingping Li

Beijing Cancer Hospital

xuedong123321@hotmail.com+86 010-88196273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026